Gynecologic Cancer
Combination extends OS in advanced endometrial cancer
Pembrolizumab plus lenvatinib improved outcomes compared with chemotherapy for women with advanced endometrial cancer, according to topline data released by the agents’ manufacturers.
Cancer led to 4 million potential years of life lost in 2017
Cancer led to 4 million potential years of life lost in 2017 in the United States, with cancers occurring in younger patients accounting for a disproportionate amount of the burden, according to study results.
Physical activity before, after endometrial cancer diagnosis improves survival outcomes
Recreational physical activity appeared associated with improved survival outcomes among women with endometrial cancer, according to study results published in Journal of Clinical Oncology.
FDA approves FoundationOne Liquid CDx as companion diagnostic for several cancer therapies
The FDA approved the FoundationOne Liquid CDx test as a companion diagnostic device to help identify multiple additional biomarkers in cell-free DNA isolated from plasma, according to a press release from the agency.
Women less likely than men to be asked about sexual health after cancer treatment
Most cancer survivors reported experiencing some degree of sexual dysfunction after treatment, yet women were less likely than men to report being asked about sexual health by their health care provider, according to study results.
Image-guided IMRT associated with fewer gastrointestinal adverse events in cervical cancer
Image-guided intensity-modulated radiation therapy resulted in fewer gastrointestinal adverse events than 3D conformal radiation among women with cervical cancer, according to a phase 3 study presented at the virtual ASTRO Annual Meeting.
Incomplete pregnancies linked to reduced risk for ovarian cancer
Incomplete pregnancies appeared associated with reduced risk for invasive epithelial ovarian cancer, according to results of a study published in Journal of the National Cancer Institute.
Early post-therapy HPV clearance linked to improved survival in cervical cancer
Early post-therapy clearance of HPV appeared associated with improved survival among women with cervical cancer, according to results of a prospective study published in Cancer.
USC professor honored with distinguished lectureship
American Association for Cancer Research honored Lourdes A. Báezconde-Garbanati, PhD, with the AACR Distinguished Lectureship on the Science of Cancer Health Disparities.
HPV vaccination substantially reduces risk for invasive cervical cancer
Quadrivalent HPV vaccination substantially reduced the risk for invasive cervical cancer among Swedish girls and women aged 10 to 30 years, according to results of a study published in The New England Journal of Medicine.